Fundz

ThruFlo Endovascular raises an undisclosed amount in Seed funding led by Atlas MedInnovation to establish R&D operations and submit an IDE application to the FDA.

PRIVATEJun 11, 2026

Round Type

Seed

IrvineBiotechnologyHealth CareMedicalMedical Device

Investors

Atlas MedInnovation

Description

ThruFlo Endovascular, Inc., based in Irvine, CA, raised an undisclosed amount in Seed funding. The round was led by Atlas MedInnovation. The funding will help establish formal R&D operations, complete device design, and initiate pre-clinical studies. Their innovative device aims to treat cerebral aneurysms with a unique Y-shaped design.

Quick answer

ThruFlo Endovascular raised an undisclosed amount in a Seed round, dated June 11, 2026. Investors: Atlas MedInnovation. ThruFlo Endovascular is based in Irvine, California, United States.

How much did ThruFlo Endovascular raise?
ThruFlo Endovascular raised an undisclosed amount in a Seed round on June 11, 2026.
Who invested in ThruFlo Endovascular?
Atlas MedInnovation is named as investors in this round.
What does ThruFlo Endovascular do?
ThruFlo Endovascular is a neuro-endovascular medical device company developing advanced technology to treat cerebral (brain) aneurysms, particularly bifurcation aneurysms.
Where is ThruFlo Endovascular based and how big is it?
ThruFlo Endovascular is based in Irvine, California, United States. Fundz records about 11 employees.

Source: Fundz verified event record.

Who to call at ThruFlo Endovascular, and when

A new round usually means ThruFlo Endovascular is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ThruFlo Endovascular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ThruFlo Endovascular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ThruFlo Endovascular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ThruFlo Endovascular

Location

Irvine, California, United States

About

ThruFlo Endovascular is a neuro-endovascular medical device company developing advanced technology to treat cerebral (brain) aneurysms, particularly bifurcation aneurysms. Their device features an anatomically specific, dual-branch, Y-shaped design that deploys as a single modality, eliminating the need for coiling and reducing procedural complexity, time, and risk.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ThruFlo Endovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ThruFlo Endovascular's next move

See what Strategic adds

ThruFlo Endovascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.